-
1
المؤلفون: Oya Karadağ, Esat Mahmut Özşahin, Candan Demiröz, Günhan Cebelli, Lütfi Özkan
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı., Demiröz, Candan, Özkan, Lütfi, Karadağ, Oya
المصدر: Turkiye Klinikleri Journal of Medical Sciences. 32:1207-1216
مصطلحات موضوعية: Male, Oncology, medicine.medical_treatment, Skin manifestation, Amifostine, 2 (3 Aminopropylamino)Ethanethiol, Radioprotective Effect, Cancer growth, Overall survival, Subcutaneous amifostine, Head and neck cancer, Drug tolerability, Drug withdrawal, Radiation dose, Radiation hazard, Dose radioiodine treatment, Salivary-glands, Anemia, Nausea, Dysphagia, General Medicine, Medicine, general & internal, Cancer radiotherapy, Distant metastasis, Female, Cancer chemotherapy, Hypotension, Human, medicine.drug, Adult, Amifostin, medicine.medical_specialty, Squamous-cell carcinoma, Radyoterapi, Vomiting, Drug response, Hyperfractionated radiotherapy, Major clinical study, Xerostomia, Article, Syncope, Treatment duration, Mucosa inflammation, Locally advanced head, Internal medicine, Concomitant-boost, medicine, Multimodality cancer therapy, Radiation injury, Aged, Randomized phase-II, Radiotherapy, business.industry, Follow up, Leukopenia, Baş ve boyun kanseri, medicine.disease, Fibrosis, Thrombocytopenia, Cancer survival, Drug effect, Radiation therapy, Drug efficacy, Outcome assessment, Kserostomi, Therapy, General & internal medicine, Cisplatin, business, Controlled study, Drug eruption
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b73b1ff5101f780339d3d75ddc4e58fbTest
https://doi.org/10.5336/medsci.2011-23100Test -
2
المؤلفون: Pentheroudakis, George, Pavlidis, Nicholas
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Pentheroudakis, George [0000-0002-6632-2462]
المصدر: Expert opinion on pharmacotherapy
مصطلحات موضوعية: Drug dose regimen, Oncology, Hydrocortisone, Carcinogenesis, Life expectancy, medicine.medical_treatment, Dermatitis, Review, Antipyretic agent, Diagnostic accuracy, Dna topoisomerases, Breast cancer, Leukoencephalopathy, Antineoplastic agents, Meningeal Neoplasms, Pharmacology (medical), Enzyme Inhibitors, Cerebrospinal fluid analysis, Injections, Spinal, Adenocarcinoma/pathology, Enzyme Inhibitors/therapeutic use, Palliative Care, Headache, General Medicine, Prognosis, Antineoplastic, Alkylating, Management, Arachnoid Cysts, Clinical trial, Nuclear magnetic resonance imaging, Spinal cord disease, Randomized controlled trials, Reverse transcription polymerase chain reaction, fluid/therapeutic use, Topotecan/therapeutic use, Rituximab, Lymphoma/pathology, Human, Antimetabolites, Antineoplastic, medicine.medical_specialty, Leptomeninx, Bone marrow suppression, Vomiting, Leptomeningeal, Adenocarcinoma, Irinotecan, Beta 2 microglobulin, Disease association, Drug formulation, Meningism, Humans, Combined Modality Therapy, Molecular mechanics, Antineoplastic Agents, Alkylating, High risk population, Steroid, Pharmacology, Carcinoma/*drug therapy/radiotherapy/secondary, Type i, medicine.disease, Lymphoma, Radiation therapy, Myelin basic protein, Methotrexate, Arachnoiditis, Delayed-Action Preparations, Laboratory diagnosis, Risk factor, Topoisomerase I Inhibitors, Palliative care, Antimetabolites, Meningeal Neoplasms/*drug therapy/radiotherapy/secondary, Dexamethasone, Cancer risk, Arachnoid cysts, Photophobia, Thiotepa/administration & dosage/cerebrospinal fluid/therapeutic use, Nephrotoxicity, Randomized Controlled Trials as Topic, Meningeal metastasis, Leukemia, Cytarabine, Folinic acid, Lactate dehydrogenase, Nausea, Combined modality therapy, Enzyme inhibitors, Antineoplastic Agents, Alkylating/administration & dosage/cerebrospinal, Sensitivity and specificity, Cranial irradiation, Injections, Intravenous, Cytarabine/administration & dosage/cerebrospinal fluid/therapeutic use, Meningeal neoplasms, Mafosfamide, Intravenous, Carcinomatous meningitis, Algorithms, Drug elimination, Fever, Spinal, Liver toxicity, Drug response, Cerebellum disease, Arachnoid Cysts/*drug therapy/etiology/radiotherapy, Drug half life, Neuroimaging, Malignancy, Injections, Methotrexate/administration & dosage/cerebrospinal fluid/therapeutic use, Aseptic meningitis, Mucosa inflammation, Internal medicine, Computer assisted tomography, Temozolomide, medicine, Leukemia/pathology, Antimetabolites, Antineoplastic/administration & dosage/cerebrospinal, Vasculotropin, Performance status, business.industry, Carcinoma, Trastuzumab, Cancer survival, Surgery, Drug efficacy, Carcinoembryonic antigen, Delayed-action preparations, Cranial Irradiation, Antiemetic agent, Topotecan, Cytology, business, Thiotepa
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::833bf06fd03c56e21514d92c7baec460Test
https://doi.org/10.1517/14656566.6.7.1115Test -
3
المؤلفون: Murat Arslan, Ender Kurt, Guzin Gonullu, Mutlu Demiray, Ozkan Kanat, Osman Manavoglu, Turkkan Evrensel
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Bilim Dalı., Kanat, Özkan, Evrensel, Türkkan, Kurt, Ender, Demiray, Mutlu, Gönüllü, Güzin, Arslan, Murat, Manavoğlu, Osman, AAJ-1027-2021, M-8060-2019
المصدر: Tumori Journal. 90:192-195
مصطلحات موضوعية: Male, Oncology, Cancer Research, Phases of clinical research, Single Center, Deoxycytidine, Gastroenterology, Trial, Metastasis, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Bolus (medicine), Antineoplastic Combined Chemotherapy Protocols, 5-fluorouracil, Pancreas cancer, Survival time, Drug tolerability, Analgesics, Leukopenia, Anemia, Pancreas Adenocarcinoma, Gemcitabine, Pancreatic Neoplasms, General Medicine, Middle Aged, Serotonin 3 antagonist, Clinical trial, Treatment Outcome, Fluorouracil, 030220 oncology & carcinogenesis, Injections, Intravenous, Disease Progression, Female, medicine.symptom, Human, medicine.drug, Adult, Diarrhea, Antimetabolites, Antineoplastic, medicine.medical_specialty, Clinical article, Drug response, Adenocarcinoma, Drug Administration Schedule, Article, Drug toxicity, 03 medical and health sciences, Mucosa inflammation, Internal medicine, medicine, Mucositis, Humans, Chemotherapy, High-dose leucovorin, Phase 2 clinical trial, Aged, business.industry, Body Weight, Pancreatic cancer, medicine.disease, Survival Analysis, Thrombocytopenia, Cancer survival, Cancer combination chemotherapy, Drug effect, Drug efficacy, Regimen, Tract cancer, Antiemetic agent, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb1e7af86667f6cfc6f7a594cb91f8e8Test
https://doi.org/10.1177/030089160409000206Test -
4
المؤلفون: Aravantinos, Gerasimos, Bafaloukos, Dimitrios, Fountzilas, George, Christodoulou, C., Papadimitriou, C., Pavlidis, Nicholas, Kalofonos, H. P., Gogas, H., Kosmidis, Paraskevas A., Dimopoulos, M. A.
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Aravantinos, Gerasimos [0000-0002-2106-1713], Kalofonos, H. P. [0000-0002-3286-778X]
المصدر: Annals of Oncology
مصطلحات موضوعية: medicine.medical_treatment, Docetaxel, Skin disease, Gastroenterology, Carboplatin, Granulocyte colony-stimulating factor, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Prospective Studies, Treatment outcome, Drug safety, Etoposide, Ovarian Neoplasms, Multicenter study, Clinical trial, Oxaliplatin, Local, Oncology, Vertigo, Disease Progression, Taxoids, Infection, Human, Diarrhea, Neoplasm recurrence, medicine.medical_specialty, Bone marrow suppression, Paclitaxel, Clinical article, Febrile neutropenia, Antineoplastic Agents, Methylprednisolone, Article, Disease-Free Survival, Ovarian cancer, Humans, Platinum-resistant, Cancer recurrence, Aged, Disease progression, Drug infusion, Recombinant granulocyte colony stimulating factor, Follow up, Myalgia, Leukopenia, Monotherapy, medicine.disease, Cancer combination chemotherapy, Drug effect, Regimen, Drug resistance, Cisplatin, Ovarian neoplasms, Controlled clinical trial, Nausea and vomiting, Phytogenic, Middle aged, Fatigue, Priority journal, Platinum derivative, Anemia, Vinorelbine, Hematology, Middle Aged, Arthralgia, Ondansetron, Anorexia, Treatment Outcome, Drug choice, Female, medicine.symptom, medicine.drug, Adult, Abdominal pain, Neutropenia, Ovary cancer, Disease-free survival, Navelbine, Vinblastine, Mucosa inflammation, Antineoplastic combined chemotherapy protocols, Internal medicine, Neurotoxicity, medicine, Chemotherapy, Phase 2 clinical trial, Stomatitis, business.industry, Alopecia, Taxane derivative, Gemcitabine, Thrombocytopenia, Antineoplastic Agents, Phytogenic, Cancer survival, Surgery, Drug efficacy, Doxorubicin, Drug Resistance, Neoplasm, Neoplasm, Neoplasm Recurrence, Local, Antiemetic agent, Topotecan, business, Controlled study, Constipation, Prospective studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e836ea784e7dd1d62801cbb6bcc90bTest
https://doi.org/10.1093/annonc/mdg292Test -
5دورية أكاديمية
المساهمون: Pavlidis, Nicholas 0000-0002-2195-9961, Pentheroudakis, George 0000-0002-6632-2462, Boussios, Stergios 0000-0002-2512-6131
المصدر: Annals of Gastroenterology
مصطلحات موضوعية: Antineoplastic agent, Cisplatin, Cytarabine, Dacarbazine, Doxorubicin, Fluorouracil, Human, Methotrexate, Patient care, Procarbazine, Carboplatin, Chemotherapy, Abdominal pain, Anorexia, Bone marrow suppression, Constipation, Diarrhea, Drug efficacy, Mucosa inflammation, Nausea and vomiting, Ondansetron, Oxaliplatin, Stomatitis, Taxane derivative, Review, Erlotinib, Imatinib, Unindexed drug, Gastrointestinal symptom, Incidence
-
6
المؤلفون: Fountzilas, George, Dafni, U., Papadimitriou, C., Timotheadou, E., Gogas, H., Eleftheraki, A. G., Xanthakis, I., Christodoulou, C., Koutras, A. K., Papandreou, C. N., Papakostas, P., Miliaras, S., Markopoulos, C., Dimitrakakis, C., Korantzopoulos, Panagiotis, Karanikiotis, C., Bafaloukos, Dimitrios, Kosmidis, Paraskevas A., Samantas, E., Varthalitis, I., Pavlidis, Nicholas, Pectasides, Dimitrios, Dimopoulos, M. A.
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]
المصدر: BMC Cancer
مصطلحات موضوعية: Oncology, Survival rate, Neurologic disease, Docetaxel, Skin disease, Multiple cycle treatment, Eye disease, Breast cancer, Phase 3 clinical trial, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Pathology, Drug fatality, Anthracyclines, Disease free survival, Open study, Fulvestrant, Mastectomy, Dose-dense sequential chemotherapy, Multicenter study, Clinical trial, Antineoplastic agent, Randomized controlled trial, Granulocyte colony stimulating factor, Goserelin, Thrombocyte, Infection, Human, Diarrhea, medicine.medical_specialty, Paclitaxel, Vomiting, Febrile neutropenia, Heart failure, Antineoplastic Agents, Major clinical study, Side effect, Heart disease, Anastrozole, Vascular disease, Article, Disease-Free Survival, Drug Administration Schedule, Epidermal growth factor receptor 2, Taxanes, Median follow-up, Genetics, Humans, Hemoglobin, Phase 3 clinical trial (topic), Cyclophosphamide, Aged, Follow up, Leukopenia, Myalgia, medicine.disease, Metabolic disorder, Cancer combination chemotherapy, Regimen, Tamoxifen, Methotrexate, Cancer adjuvant therapy, Asymptomatic disease, Comparative study, Breast neoplasms, Cancer Research, Partial mastectomy, Heart ejection fraction, Gonadorelin, Skin manifestation, Monoclonal, Edema, Overall survival, Middle aged, Humanized, Fatigue, Adjuvant, Drug withdrawal, Neutrophil, Nausea, Middle Aged, Gastrointestinal disease, Arthralgia, Anorexia, Chemotherapy, Adjuvant, Cancer radiotherapy, Female, Fluorouracil, Epirubicin, medicine.drug, Research Article, Monoclonal antibody, Adult, Neutropenia, Disease-free survival, Pain, Breast Neoplasms, Follow-up studies, Antibodies, Monoclonal, Humanized, Antibodies, Young Adult, Mucosa inflammation, Internal medicine, Antineoplastic combined chemotherapy protocols, medicine, Chemotherapy, Early cancer, Taxane, business.industry, Drug administration, Loading drug dose, Lymphocytopenia, Drug administration schedule, Allergic reaction, Patient compliance, Aromatase inhibitor, Leukocyte, Trastuzumab, Adjuvant chemotherapy, Drug efficacy, Young adult, Lung disease, business, Controlled study, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f05a4fb1c5cce316e6477713a4950eTest
https://pubmed.ncbi.nlm.nih.gov/25026897Test -
7
المؤلفون: Karabulut, Bülent, Özdemir, Feyyaz, Tunalı, Didem
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Veterinerlik Fakültesi/Radyasyon Onkolojisi Anabilim Dalı., Kurt, Ender, Çubukçu, Erdem, Ölmez, Ömer Fatih, Kurt, Meral, Avcı, Nilüfer, Evrensel, Türkkan, Manavoǧlu, Osman, AAJ-1027-2021, AAA-3961-2020
مصطلحات موضوعية: Male, Turkey, Systemic treatment, Docetaxel, Carboplatin, Multiple cycle treatment, Elderly, Overall survival, Treatment outcome, Disease course, Drug safety, Survival time, Drug tolerability, Anemia, Anorexia, Oxaliplatin, Retrospective study, Oncology, Female, Taxoids, Fluorouracil, Age factors, Human, Neutropenia, Paclitaxel, Disease-free survival, Stomach cancer, Clinical article, Stomach neoplasms, Drug response, Adenocarcinoma, Article, Mucosa inflammation, Antineoplastic combined chemotherapy protocols, Advanced cancer, Humans, Ramucirumab, Rivoceranib, Line, Aged, Stomatitis, 1st-line chemotherapy, Time factors, Post treatment survival, Phase-II trial, Kaplan-meier estimate, Thrombocytopenia, RAndomized-trial, Cancer survival, Cancer combination chemotherapy, Retrospective studies, Older, Drug efficacy, Geriatric patient, Progression free survival, Cisplatin, Gastric cancer
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______9458::cd36031629b181314823467479cfa5b7Test
http://hdl.handle.net/11452/32810Test -
8دورية أكاديمية
المؤلفون: Lazaridis, G., Pentheroudakis, George, Pavlidis, Nicholas
المساهمون: Pavlidis, Nicholas 0000-0002-2195-9961, Pentheroudakis, George 0000-0002-6632-2462
المصدر: Critical reviews in oncology/hematology
مصطلحات موضوعية: Female, Antineoplastic agents, Cyclophosphamide, Doxorubicin, Human, Humans, Breast neoplasms, Carboplatin, Paclitaxel, Alopecia, Anemia, Antineoplastic combined chemotherapy protocols, Arthralgia, Constipation, Drug efficacy, Drug safety, Fatigue, Febrile neutropenia, Infection, Leukopenia, Mucosa inflammation, Navelbine, Neutropenia, Stomatitis, Thrombocytopenia, Cardiotoxicity, Disease free survival, Review, Docetaxel, Overall survival
الإتاحة: https://doi.org/10.1016/j.critrevonc.2007.07.002Test
https://gnosis.library.ucy.ac.cy/handle/7/42119Test -
9دورية أكاديمية
المؤلفون: Briassoulis, E. Ch, Pentheroudakis, George, Karavasilis, V., Tzamakou, E., Rammou, D., Pavlidis, Nicholas
المساهمون: Pavlidis, Nicholas 0000-0002-2195-9961, Pentheroudakis, George 0000-0002-6632-2462, Karavasilis, V. 0000-0002-5806-9399
المصدر: Annals of Oncology
مصطلحات موضوعية: Article, Doxorubicin, Human, Neoplasms, 80 and over, Aged, Humans, Adult, Cancer patient, Controlled study, Female, Middle aged, Advanced cancer, Cancer combination chemotherapy, Drug response, Priority journal, Alopecia, Antineoplastic combined chemotherapy protocols, Clinical article, Clinical trial, Controlled clinical trial, Diarrhea, Drug efficacy, Fatigue, Febrile neutropenia, Infection, Methylprednisolone, Mucosa inflammation, Nausea and vomiting, Neurotoxicity
الإتاحة: https://doi.org/10.1093/annonc/mdh404Test
https://gnosis.library.ucy.ac.cy/handle/7/41419Test -
10
المؤلفون: Fountzilas, George, Papakostas, P., Dafni, U., Makatsoris, T., Karina, M., Kalogera-Fountzila, Anna, Maniadakis, N., Aravantinos, Gerasimos, Syrigos, K., Bamias, A. T., Christodoulou, C., Economopoulos, T., Kalofonos, H. P., Nikolaou, A., Angouridakis, N., Stathopoulos, G. P., Bafaloukos, Dimitrios, Pavlidis, Nicholas, Daniilidis, J.
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Aravantinos, Gerasimos [0000-0002-2106-1713], Kalogera-Fountzila, Anna [0000-0002-6801-3129], Kalofonos, H. P. [0000-0002-3286-778X]
المصدر: Annals of Oncology
مصطلحات موضوعية: Oncology, Drug dose regimen, Male, Hand foot syndrome, medicine.medical_treatment, Deoxycytidine, law.invention, Polyethylene Glycols, Phase 3 clinical trial, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Drug fatality, Bleeding disorder, Survival time, Aged, 80 and over, Greece, Gefitinib, Carcinoma, Squamous Cell/*drug therapy/*economics/mortality, Clinical trial, Antineoplastic agent, Doxorubicin/administration & dosage/adverse effects/analogs &, Head and Neck Neoplasms, Randomized controlled trial, Granulocyte colony stimulating factor, Carcinoma, Squamous Cell, Bisphosphonic acid derivative, derivatives/economics, Infection, Human, Diarrhea, medicine.medical_specialty, Paclitaxel, Vomiting, Febrile neutropenia, Major clinical study, Antimetabolite, Polyethylene Glycols/administration & dosage/adverse effects/economics, Article, Amifostine, Humans, Patient Compliance/statistics & numerical data, Aged, Leukopenia, Myalgia, medicine.disease, Survival Analysis, Regimen, Peripheral neuropathy, Cost-Benefit Analysis, Dexamethasone, Head and Neck Neoplasms/*drug therapy/*economics/mortality, law, Controlled clinical trial, Cost benefit analysis, Head and neck cancer, Fatigue, Priority journal, Drug tolerability, Antibiotic agent, Polyethylene glycols, Pyridoxine, Anemia, Nausea, Deoxycytidine/administration & dosage/adverse effects/analogs &, Hematology, Middle Aged, Chemotherapy regimen, Arthralgia, Ondansetron, Statistical significance, Treatment Outcome, Sensory neuropathy, Female, medicine.drug, Drug hypersensitivity, Adult, Neutropenia, medicine.drug_class, Bone marrow toxicity, Head and neck neoplasms, Mucosa inflammation, Health care organization, Internal medicine, Advanced cancer, Antineoplastic combined chemotherapy protocols, Nasopharynx cancer, medicine, Neurotoxicity, Chemotherapy, Erythropoietin, Paclitaxel/administration & dosage/adverse effects/economics, business.industry, Squamous cell, Carcinoma, Alopecia, Patient compliance, New drug, Thrombocytopenia, Gemcitabine, Cancer survival, Drug efficacy, Antineoplastic Combined Chemotherapy Protocols/adverse, Doxorubicin, Patient Compliance, Cancer patient, business, Antiemetic agent, Controlled study, Constipation, effects/*economics/*therapeutic use
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f06d2f8f00f810b227da9d55f67e00Test
http://olympias.lib.uoi.gr/jspui/handle/123456789/19490Test
